Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.